\
&
Contact us
\
&
Contact us
This was 6 years ago
LocationKANAL-Centre Pompidou
Quai des Péniches
1000 Brussels, Belgium.
Update 24/9/2019: all sessions will be web streamed
The event, which is open to everyone and is free of charge, will feature three main elements: a high-level Policy Conference, the Innovative Europe Hub and the ‘Science is Wonderful’ exhibition of EU-funded projects. This event will be an important part of the strategic planning process that sets the foundations for the first work programmes of Horizon Europe.
Keep up to date with the programme on the conference website and by following on Twitter/Facebook @EUScienceInnov using the conference hashtag #RiDaysEU.
Registrations are open!
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
